Calcium and vitamin D intake by postmenopausal women with osteoporosis in France

Current Medical Research and Opinion

Volumn 26, Issue 7, 2010, Pages 1667-1674

  Czernichow, Sébastien ^a,b   Fan, Tao ^c   Nocea, Gonzalo ^d   Sen, Shuvayu Sankar ^c  

^a UNIVERSITÉ PARIS 13   (France)

^b University of Paris Cité   (France)

^c MERCK RESEARCH LABORATORIES   (United States)

^d MSD   (Spain)

Author keywords

Calcium; Dietary supplements; Food intake; Osteoporosis; Vitamin D

Indexed keywords

ALENDRONIC ACID; ALENDRONIC ACID PLUS COLECALCIFEROL; CALCITONIN; CALCIUM; ERGOCALCIFEROL; ESTROGEN; ETIDRONIC ACID; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STRONTIUM; VITAMIN D; BONE DENSITY CONSERVATION AGENT; CALCIUM INTAKE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DOSE COMPARISON; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; FRANCE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; NUTRITIONAL SUPPORT; PHYSICIAN; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SUN EXPOSURE; TELEPHONE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ADMINISTRATION AND DOSAGE; CALCIUM INTAKE; DOSE RESPONSE; EATING; EVALUATION STUDY; HEALTH CARE POLICY; INFORMATION PROCESSING; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHYSIOLOGY; QUESTIONNAIRE; UTILIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; DATA COLLECTION; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEMALE; FRANCE; HUMANS; MIDDLE AGED; NUTRITION POLICY; OSTEOPOROSIS, POSTMENOPAUSAL; QUESTIONNAIRES; VITAMIN D;

EID: 77953590173     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.483658     Document Type: Article

References (47)

1. Holick MF. The vitamin D deficiency pandemic and consequences for non-skeletal health: mechanisms of action. Mol Aspects Med 2008;29:361-368
2. Anderson PH, Atkins GJ. The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 2008;29:397-406
3. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-373
4. Holick MF. The vitamin D epidemic and its health consequences. J Nutr 2005;135:2739S-48S
5. Ginde AA, Liu MC, Camargo Jr CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-632
6. Wolff AE, Jones AN, Hansen KE. Vitamin D and musculoskeletal health. Nat Clin Pract Rheumatol 2008;4:580-588
7. Harris S. Emerging roles of vitamin D: more reasons to address widespread vitamin D insufficiency. Mol Aspects Med 2008;29:359-360
8. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-795
9. Dawson-Hughes B. A revised clinician's guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab 2008;93:2463-2465
10. Rizzoli R, Boonen S, Brandi ML, et al. Calcium and Vitamin D in the Management of Osteoporosis: The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, 2007
11. Hautvast JG, Baya C, Amorim Cruz JA, et al. Recommended dietary allowances for Europe. Lancet 1989;2:1220
12. Moniz C, Dew T, Dixon T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin 2005;21:1891-1894
13. Neuprez A, Bruyere O, Collette J, et al. Vitamin D inadequacy in Belgian postmenopausal osteoporotic women. BMC Public Health 2007;7:64
14. Gaugris S, Heaney RP, Boonen S, et al. Vitamin D inadequacy among post-menopausal women: a systematic review. QJM 2005;98:667-676
15. Edwards BJ, Langman CB, Bunta AD, et al. Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int 2008;19:991-999
16. Osteoporose. Strategie de Prevention et de Traitement. Paris: INSERM, 1996
17. Grados F, Marcelli C, Dargent-Molina P, et al. Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study. Bone 2004;34:362-367
18. Baudoin C. The cost of osteoporosis in France. Rev Rhum Engl Ed 1997; 64:441-442
19. Maravic M, Le Bihan C, Landais P, et al. Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database. Osteoporos Int 2005;16:1475-1480
20. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009:CD000227
21. Bischoff-Ferrari H, Shao A, Dawson-Hughes B, et al. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int published online Dec. 3, 2009
22. Lips P, Hosking D, Lippuner K, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006;260:245-254
23. National Health and Nutrition Examination Survey, 2009. Available at: http://www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm [Last accessed 18 December 2009]
24. Fan T, Bogle S, Nocea G, et al. Validity and reproducibility of questionnaire about preventive behaviors among French and Spanish postmenopausal women with osteoporosis in the Calcium and Vitamin Intake (CaVit) Study. Calcif Tissue Int 2008;82:S188
25. Hercberg S, Preziosi P, Briancon S, et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study-design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin Trials 1998;19:336-351
26. Table de Composition des Aliments SU.VI.MAX. Paris, France: INSERM/Economica 2006
27. Human Vitamin and Mineral Requirements. Bangkok: FAO/WHO, 2002
28. Cumming C, Gopalan C, Hallberg L, et al. Human Vitamin and Mineral Requirements. Report of a Joint FAO/WHO Expert Consultation, Bangkok. Thailand. Rome: Food and Nutrition Division, FAO; 2001.
29. Bruyere O, De Cock C, Mottet C, et al. Low dietary calcium in European postmenopausal osteoporotic women. Public Health Nutr 2009;12:111-114
30. Touvier M, Lioret S, Vanrullen I, et al. Vitamin and mineral inadequacy in the French population: estimation and application for the optimization of food fortification. Int J Vitam Nutr Res 2006;76:343-351
31. Carriere I, Delcourt C, Lacroux A, et al. Nutrient intake in an elderly population in southern France (POLANUT): deficiency in some vitamins, minerals and omega-3 PUFA. Int J Vitam Nutr Res 2007;77:57-65
32. Bruyere O, Malaise O, Neuprez A, et al. Prevalence of vitamin D inadequacy in European postmenopausal women. Curr Med Res Opin 2007;23:1939-1944
33. Garnero P, Munoz F, Sornay-Rendu E, et al. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 2007;40:716-722
34. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007;103:620-625
35. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439-443
36. Malochet-Guinamand S, Chalard N, Billault C, et al. Osteoporosis treatment in postmenopausal women after peripheral fractures: impact of information to general practitioners. Joint Bone Spine 2005;72:562-566
37. Bayly JR, Hollands RD, Riordan-Jones SE, et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Curr Med Res Opin 2006;22:131-137
38. Hanley DA, Zhang Q, Meilleur MC, et al. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada. Curr Med Res Opin 2007;23:1473-1480
39. Resch H, Walliser J, Phillips S, et al. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective. Curr Med Res Opin 2007;23:1227-1237
40. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-683
41. Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-1628
42. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess 2007; 158:1-235
43. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007;92:1415-1423
44. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370: 657-666
45. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169:551-561
46. Bischoff-Ferrari H. Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary? Best Pract Res Clin Rheumatol 2009;23:789-795
47. Perez-Lopez FR. Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 2007;58:117-137